These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Metabolic modulation in heart failure: high time for a definitive clinical trial. Ashrafian H, Neubauer S. Heart; 2011 Feb; 97(4):267-8. PubMed ID: 21258118 [No Abstract] [Full Text] [Related]
6. Metabolic treatment of myocardial ischaemia. Ferrari R. Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019 [No Abstract] [Full Text] [Related]
7. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A. Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466 [Abstract] [Full Text] [Related]
8. Metabolic modulation: a new therapeutic target in treatment of heart failure. Palaniswamy C, Mellana WM, Selvaraj DR, Mohan D. Am J Ther; 2011 Nov; 18(6):e197-201. PubMed ID: 20393344 [Abstract] [Full Text] [Related]
9. Trimetazidine: the future of cardiac function? Di Napoli P, Taccardi AA. Future Cardiol; 2009 Sep; 5(5):421-4. PubMed ID: 19715405 [No Abstract] [Full Text] [Related]
13. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease]. Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK. Klin Med (Mosk); 2004 Feb; 82(11):15-20. PubMed ID: 15656392 [Abstract] [Full Text] [Related]
14. Modulation of myocardial energetics: An important category of agents in the multimodal treatment of coronary artery disease and heart failure. Dalal JJ, Mishra S. Indian Heart J; 2017 Feb; 69(3):393-401. PubMed ID: 28648439 [Abstract] [Full Text] [Related]
15. Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Rosano GM, Vitale C, Fragasso G. Am J Cardiol; 2006 Sep 04; 98(5A):14J-18J. PubMed ID: 16931201 [Abstract] [Full Text] [Related]
16. [Trimetazidine in the Treatment of Chronic HeartFailure]. Zhirov IV, Osmolovskaya YF, Tereshchenko SN. Kardiologiia; 2016 Jan 04; 56(1):79-85. PubMed ID: 28294737 [Abstract] [Full Text] [Related]
17. The adrenergic-fatty acid load in heart failure. Opie LH, Knuuti J. J Am Coll Cardiol; 2009 Oct 27; 54(18):1637-46. PubMed ID: 19850204 [Abstract] [Full Text] [Related]
18. Trimetazidine and cardioprotection: facts and perspectives. Tsioufis K, Andrikopoulos G, Manolis A. Angiology; 2015 Mar 27; 66(3):204-10. PubMed ID: 24719262 [Abstract] [Full Text] [Related]
19. The metabolic treatment of coronary artery disease and heart failure. Di Napoli P. Curr Pharm Des; 2009 Mar 27; 15(8):826. PubMed ID: 19275645 [No Abstract] [Full Text] [Related]
20. Vasodilator and inotropic therapy for heart failure. DiPalma JR. Am Fam Physician; 1985 Jun 27; 31(6):177-80. PubMed ID: 4013962 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]